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KAJIAN METABOLISME DRUG DAN TOKSISITI Orthosiphon stamineus, Benth 
(MISAI KUCING) DALAM TIKUS 
ABSTRAK 
Orthosiphon stamineus, Benth (Famili: Lamiceae) atau dikenali dengan nama 
tempatan sebagai Misai Kucing, digunakan secara meluas di Malaysia untuk merawat 
hipertensi, masalah sistem urinasi dan penyakit batu karang ginjal. Objektif kajian ini 
ialah untuk mengkaji kesan ekstrak metanol Misai Kucing piawai ke atas enzim 
penghadarnan drug hepatik fasa I dan II di dalam tikus Sprague-Oawley (SO). 
Aminopirin, p-nitrofenol (pNP) dan 1-kloro, 2,4-dinitrobenzena (CONS) telah digunakan 
sebagai substrat untuk menentukan aktiviti aminopirin N-demetilase, 
UOP-glukuronosiltransferase (UGT) dan glutatione-S-transferase (GST) masing-
masing di dalam hati tikus SO. Pengasingan hepatosit, fraksi sitosolik hati dan 
mikrosom telah disediakan dengan menggunakan teknik perfusi kolagenase dan 
pengemparan berperingkat. Kesan ketoksikan serta anti-hepatotoksik oleh ekstrak 
metanol Misai Kucing piawai ke atas tikus SO juga diuji. Oaripada keputusan yang 
diperolehi, kebanyakan aktiviti UGT dan GST di dalam hati tikus SO normal dan 
diabetik adalah dipengaruhi secara signifikan oleh ekstrak metanol Misai Kucing 
piawai. Hanya beberapa kumpulan tikus SO normal dan diabetic menunjukkan kesan 
yang signifikan terhadap metabolisme aminopirin oleh ekstrak methanol Misai Kucing 
piawai. Kemungkinan mekanisme tindakan in vitro 1 mg/ml ekstrak metanol Misai 
Kucing ke atas metabolisme aminopirin di dalam hepatosit tikus jantan tua normal 
adalah melalui pengaktifan G-protein dan protein kinase C manakala kesan in vitro 
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0.001 mg/ml ekstrak metanol Misai Kucing piawai ke atas metabolisme aminopirin di 
dalam hepatosit tikus SD betina muda adalah berkemungkinan melalui pengaktifan 
protein kinase A. Aras LD50 untuk ekUrak metanol Misai Kucing piawai tidak dapat 
ditentukan dalam ujikaji ini. Tiada kematian dan kesan toksik diperhatikan pada tikus 
jantan dan betina muda normal setelah dirawat dengan 0.5, 1.0, 3.0 dan 5.0 g/kg 
ekstrak metanol Misai Kucing piawai. Pra-rawatan dengan ekstrak metanol Misa! 
Kucing piawai dapat meningkatkan peratusan viabiliti hepatosit serta menurunkan 
setengah dari aras AST, AL T, ALP dan GGT serum di dalam tikus SD jantan dan 
betina dewasa yang dirangsang kecederaan hati dengan 2 g/kg acetaminofen. Secara 
kesimpulan, ekstrak metanol Misai Kucing piawai mempunyai kesan yang lebih besar 
ke atas aktiviti UGT dan GST jika dibandingkan dengan aktiviti aminopirin 
N-demetilase di dalam hati tikus SD. Ekstrak metanol Misai Kucing piawai pada 
0.5 g/kg adalah diklasifikasikan sebagai paras tidak menyebabkan kesan (NOEL) dan 
ia mempamerkan kesan anti-hepatotoksisiti ke atas tikus SD jantan dan betina dewasa 
yang dirangsang kerosakan hati dengan acetaminofen. 
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DRUG METABOLISM AND TOXICITY STUDIES OF Orthosiphon stamineus, Benth 
(MISAI KUCING) IN RATS 
ABSTRACT 
Orthosiphon stamineus, Benth (Family: Lamiaceae) or locally known as Misai 
Kucing, is widely used in Malaysia for treating hypertension, urinary system ailments 
and kidney stone disease. The objective of this study is to investigate the effect of 
standardised methanol extract of Misai Kucing on phase I and phase II hepatic drug 
metabolising enzymes in Sprague-Oawley (SO) rat. Aminopyrine, p-nitrophenol (pNP) 
and 1-chloro-2,4-dinitro benzene (CONB) was used as a substrate to determine the 
aminopyrine N-demethylase, UOP-glucuronosyltransferase (UGT) and glutathione-S-
transferase (GST) activity respectively in SD rat liver. Isolated hepatocytes, liver 
cytosolic fraction and liver microsomes from SO rats were prepared using the 
collagenase perfusion technique and differential centrifugation technique. The possible 
toxic and anti-hepatotoxicity effects of standardised of methanol extract of Misai Kucing 
on SO rats were also examined. Results obtained showed that most of the UGT and 
GST activity in normal and diabetic SO rat liver were significantly affected by 
standardised methanol extract of Misai Kucing. Only a few groups of normal and 
diabetic SO rats showed significant effect on aminopyrine metabolism in hepatocytes in 
the presence of standardised methanol extract of Misai Kucing. The possible 
mechanism of action ofthe in vitro effect of 1 mg/ml of standardised methanol extract 
of Misai Kucing on aminopyrine metabolism in normal old male SD rat hepatocytes 
was probably mediated through the activation of G-protein and protein kinase C while 
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the in vitro effect of 0.001 mg/ml of Misai Kucing extract on normal young female SO 
rat hepatocytes was probably mediated through the activation of protein kinase A. The 
LOse of standardised of methanol extract of Misai Kucing could not be determined in 
this study. No lethality incident and any toxic effects were observed in normal young 
male and female SO rats after being treated with 0.5, 1.0, 3.0 and 5 g/kg of 
standardised methanol extract of Misai Kucing. Pre-treatment with standardised 
methanol extract of Misai Kucing increased the percentage of hepatocytes viability and 
decreased some of the serum AST, ALT, ALP and GGT level in 2g/kg of 
acetaminophen induced liver damage in adult male and female SO rats. In conclusion, 
standardised methanol extract of Misai Kucing had a greater influence on UGT and 
GST activity than the aminopyrine N-demethylase activity in SO rat liver. Standardised 
methanol extract of Misai Kucing at 0.5 g/kg is classified as not-observable effect level 
(NOEL) and it exhibited anti-hepatotoxicity effect on acetaminophen-induced liver 
injury in adult male and female SO rats. 
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1.0 INTRODUCTION 
CHAPTER ONE 
GENERAL INTRODUCTION 
1.1 Use of herbal medicine worldwide 
Herbal medicine systems vary from one country to another country. Many of the 
herbal medicine practices are originated from their culture and region. Herbal medicine 
practices have been handed down from one generation to another generation and 
some countries had practiced it for hundreds and even thousand of years. For 
example, conventional United States and European herbal practices are based on 
ancient Greek-Roman experiences by using single herbs. In contrast, Chinese 
traditional herbal practice is based on formulas using multiple herbs 
(Rotblatt & Ziment, 2002). Old Chinese herbal medication especially is based on the 
experiences and absence of scientific evidence based products may not be acceptable 
by the European herbal medicine practitioners although both systems are giving same 
therapeutic effects. Many countries are still practicing herbal medicine which remains 
the backbone of medicine. 
In recent years, herbal medicine has been gaining more acceptance and 
attention around the world (Ernst, 2002). Herbal medicine has been practiced in many 
countries including Europe to Asia. Today, the World Health Organization (WHO) 
estimates that 80 % of the world's population use herbal medicine 
(Fetrow & Avila, 2000). Herbal medicine or phytomedicine is a common element in the 
practice of ayurvedic, homeopathy and traditional oriented medicine system by using 
plants for healing purposes. Botanically, herbs are defined as a plant, plant part or 
extract for medicinal usage and can also be used as foods, fragrance, spices and 
essential oils (Blumenthal & lsraelsen, 1998). There are great movements in herbal 
medicine around the world by conventionally using herbal remedies in the form of 
herbal tea or crude tablets to extracted and standardised form of herbal remedies in 
today's modern herbal medicine. The most popular botanical medications in the USA in 
1996 are echinacea, garlic, ginseng, gingko, goldenseal, mahuang, psyllium, siberian 
ginseng, saw palmetto and Cascara sagrada (Dennehy & Tsourounis, 2001 ). 
Many consumers feel more comfortable with natural herbal products because it 
is commonly believed that herbal products have fewer side effects as compared to 
modern drugs especially after chronic use. Combination of herbs with certain drugs 
may alter pharmacological action of the drugs or even produce unwanted side effects 
such as toxicity. Therefore, scientific-based evidence of herbal medicine on the 
possible herb-drug interaction and toxicity is important to ensure the efficacy, safety 
and quality of the herbal remedies-based products. 
In Malaysia, herbs are very common among the Malaysian community for 
medicinal purpose, foods and supplements. They used different part of the plant such 
as leaf, stem, root, flower or even seeds for medicinal purposes. A variety of herbal 
products are increasingly available at the Malaysian local market and many of these 
herbal products are sold as over-the-counter (OTC) medicine. One can easily find 
traditional medicine practitioners in Malay villages such as "nujum" (clairvoyant), 
"bomoh" or "mak bidan" to help in diagnosing illnesses and diseases. Normally they 
use certain type of plants like limau nipis or limau purut or even pap rice for medicinal 
purposes (Muhammad & Mustafa, 1994). Recently, numerous studies on local herbals 
have been studied extensively in Malaysia. Many scientific studies have proven that 
local traditional herbs such as Tongkat Ali (Eurycoma longifolia), Hempedu Bumi 
(Andrographis panicu/ata), Kacip Fatimah (Labisia pumila), Lempoyang (Zingiber 
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zerumbet) exhibit medicinal value for treatment of various diseases. Many other 
research on its use of herbs for medication are currently underway. 
1.1.1 The usage of herbs to treat diseases 
Worldwide, there are at least 250,000 species of flowering plants. In the 
Southeast Asia alone, there are about 35,000 species of flowering plants of which 
8,000 species are found in Malaysia (Muhammad & Mustafa, 1994). Malaysia is 
endowed with a large biodiversity of flora and fauna. Traditionally, unprocessed herbs 
are used for medicinal purposes. For instance, herbs are prepared as tea for internal 
use by boiling the parts of plant with water. Currently, herbal preparation has changed 
to extraction of the herbs with different organic solvents to increase the effectiveness 
and quality of the preparation for therapeutic purposes. 
Plants contain many types of chemical compounds which help to protect it from 
predators or attract pollinators. These secondary metabolites actually are of 
therapeutic values to the human. Phytomedicinal chemicals are generally assigned into 
nine important categories namely alkaloids, bioflavonoids, essential oils, glycosides, 
resins, saponins, sterols, tannins and terpenes (Rotblatt & Ziment, 2002). 
i) Alkaloids are defined as basic amine group with no volatile character and their 
name always end with '-ine'. Briefly, there are 13 or more subclasses of alkaloids. 
There are imidazolesatropine, indoles, isoquinolines, amides, piperidines, pyridines, 
pyrrolidines, pyrrolizidines, quinolines, quinolizidines, steroidal, purines, and terpenoids 
(Rotblatt & Ziment, 2002). Alkaloids are found to exert multiple types of therapeutic 
effects including atropine, emetine, capsaicin, cocaine, morphine, quinine, 
methylxanthines (such as caffeine and theophylline), strychnine and nicotine 
(Fetrow & Avila, 2000). However, some alkaloids are harmful to human. 
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ii) Bioflavonoids lack nitrogen and usually contain two 6-carbon rings joined by three 
carbon atoms. About half of the 8,000 plant phenolic compounds are made up of 
flavonoids. They are found in high concentrations in many flowers, fruits ana 
vegetables (Moridani et a/., 2001 ). Flavans, flavanones, isoflavanones, flavones, 
isoflavones, chalcones, anthocyanidines and flavonolignans are the subclasses for 
flavonoids (Hodek eta/., 2002). Flavonoids are commonly believed to be antioxidants 
and antiiflammatory and protective against various cancers (Challis & Barlett, 1975). 
Rutin, quercetin, kaempferol, genistein, licoricidin, cyanidin, isoliquiritigenin, hispidol, 
coumestiol and silymarin are common example of bioflavonoid compounds that exhibit 
therapeutic effects on human and animals (Badger eta/., 2001). 
iii) Essential oils are isoprene derivatives. The important essential oils are found in 
10 classes which are assigned as alcohols, aldehydes, esters, ethers, furans, 
hydrocarbons, ketones, phenols, sesquiterpinoids and sulfur compounds 
(Rotblatt & Ziment, 2002). Essential oils are used therapeutically and also in 
aromatherapy (Sadler, 2001 ). Essential oils from mint family are used as flavors and 
drugs. 
iv) Glycosides are sugar derivaties attached to aglycones {Fetrow & Avila, 2000). 
Glycosides are subdivided into cardiac glycosides, saponins, anthraquinones, 
cyanogenic glycosides, isothiocyanates, aldehydes, phenolics, alcohols, lactones and 
coumarins. Examples of glycosides used therapeutically are digoxin in allopathic 
medicine and anthraquinones which is used as laxative {Rotblatt & Ziment, 2002). 
v) Another important phytochemical compound is called terpene. Terpenes are derived 
from 5-carbon isoprene units. These terpene groups are subdivided into 
monoterpenes, sesquiterpenes, diterpenes, triterpenes, tetraterpenes, polyterpene and 
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meroterpenes. Terpenoid compounds are mainly found in green vegetable, soy and 
grains and many have antioxidant properties (Rotblatt & Ziment, 2002). 
vi) Other compound like sterols group may benefit human; stigmasterol and 
13-sitosterol may reduce low-density lipoproteins and lower serum cholesterol level 
(Rotblatt & Ziment, 2002). 
vii) Triterpenes glycosides have widespread distribution in plants and are sometimes 
referred to as saponins as they have soap-like properties and readily form foams 
(Heinrich eta/., 2004). 
viii) Triterpenes are also components of resins and resinous exudates from plants (e.g 
frankincense and myrrh). Resins are produced following damage to the tree as a 
physical barrier to attack by fungi and bacteria. Additionally, many of the terpenoid 
components of these resins have high antimicrobial activity (Heinrich eta/., 2004). 
ix) Tannin comprises of water-soluble polyphenolic compounds, which may have high 
molecular weight. They are broadly divided into two groups i.e. hydrolysable tannins, 
which are formed by the esterification of sugars with the simple phenolic acids that are 
shikimate-derived (e.g gallic acid) and non-hydrolysable tannins which occur due to 
polymerization reactions between flavonoids (Heinrich eta/., 2004). 
1.2 Literature review of Misai Kucing (Orthosiphon stamineus, Benth) 
1.2.1 Misai Kucing plant description 
In general, Misai Kucing is a medicinal herb easily found in Southeast Asia. The 
leaves are arranged in opposite pairs. The petiole is relatively short, about 0.3 em in 
length and reddish purple in colour. The flowers are borne on verticals about 16 em 
length, white to bluish in colour with long far-exerted filaments, making it look like eat's 
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whispers (Wiart, 2002). However, there are many different types of Misai Kucing which 
can be easily distinguished by its flower, these including Orthosiphon aristatus with 
white flower and Orthosiphon grandifolis with red colour flower. Identification of the 
species of Misai Kucing is very important to control its therapeutic effects because 
each species of Misai Kucing may have its own active ingredients and are not found in 
other species of Misai Kucing. 
Misai Kucing is also found in other countries such as Thailand, Indonesia and 
Europe. In these countries, Misai Kucing is also known as yaa Nuat Maeo, Rau Meo or 
Cay Bac (Thailand), Kumis Kucing or Remujung (Indonesia), moustaches de chat 
(French) and Java Tea and Kidney Tea (European). In Malaysia, Misai Kucing can be 
seen in the garden, roadsides and wastelands. Misai Kucing is easily propagated 
through 3 or 4 noded stems cuttings from a mother plant of more than 5 months of age 
(lndubala & Ng, 2000). Misai Kucing has been cultivated for a long time. However, 
there are many important factors in determining the growth and yield of Misai Kucing. 
These factors include population density, fertilizer, soil type and weather. Recently, 
researchers from Malaysia Agriculture Research and Development Institute (MARDI) 
showed that population density of 29 333 plants/hectare with spacing of 120 em 
between row and 45 em between plants within the row for Misai Kucing on bris soil 
significantly gave highest fresh and dry yield compared to population density of 
21 333 plants/hectare or lower (Zaharah & Salbiah, 2004). 
1.2.2 Classification of Misai Kucing 
The features of Misai Kucing as described by Wiart (2002) is a beautiful 
flowering plant, flower conspicuous, white and arranged in a terminal raceme. Stamens 
of Misai Kucing are long, expanding and shaped like eat's whiskers and its leaves are 
simple, without stipules and secussate, diamond-shaped, dark green above and paler 
below and secondary nerves 5-6. The Misai Kucing's stems are quadrangular with 
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purple lines at each corner and pithy (Figure 1.1 ). Based on the features described by 
Wiart (2002), the taxonomy of Misai Kucing is: 
Class: Magnoliopsida. 
Subclass: Asteridae 
Order: Lamiales 
Family: Lamiaceae (or Labiate) 
Genus: Orthosiphon 
Species: stamineus 
Scientific name: Orthosiphon stamineus, Benth 
1.2.3 Pharmacologic effects of Misai Kucing (0. stamineus) 
Misai Kucing became a popular herbal tea among the community of Southeast 
Asia and European countries (lndubala & Ng, 2002). The Misai Kucing products are 
appearing in the forms of tea sachets, capsules and dried leaves. This plant is believed 
to have several pharmacological and therapeutic effects. The evaluations of Misai 
Kucing extract for medicinal purposes are as below: 
a) Kidney stone elimination effect: Traditionally, Misai Kucing has been widely used 
by Malaysian community as a diuretic and for treating catarrh of the bladder. Misai 
Kucing has been used to eliminate stones in the bladder (lndubala & Ng, 2002). In 
Malaysia, the leaves are used as diuretic and for treating catarrh of the bladder. A 
decoction prepared from the plants is used to eliminate stones in the bladder 
(lndubala & Ng, 2002). 
b) Diuretic effect Diuretic effect of Misai Kucing has been proven through scientific 
experiments. Hydroalcohol extract of 0. stamineus has been tested for their diuretic 
activities in rats and it revealed that they led to an increase in urine flow and urinary 
sodium excretion (Beaux eta/., 1999). 
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c) Cytotoxic effect: Some flavonoids and diterpenes isolated from Misai Kucing which 
included 7,3',4'-tri-0-methylluteolin, eupatorin and ladanein showed cytotoxic activity 
towards highly liver metastatic murine colon 26-LS carcinoma cells with the EDso value 
between 10 ~g/ml to 90 ~g/ml (Tezuka et at., 2000). A mechanism which may be 
responsible for the anticarcinogenic potency of the extract may be related to the 
modulation of drug metabolising enzymes, for example, glutathione-S-transferase 
(GST) involved in carcinogen detoxification. 
d) Cardiovascular effect Methylripariochromene A, another flavonoid isolated from 
aqueous extract of Misai Kucing exhibits hypotensive and vasodilating properties and 
decreases the cardiac output in animals (Matsubara, 1999). 
e) Anti-inflammatory effect: Researchers from Japan reported that two novel highly 
oxygenated pimarane diterpenes known as orthosiphol A and B isolated from dry 
leaves of Orthosiphon stamineus, Benth exert potent inhibitory activity against the 
inflammation induced by tumor promoters, TPA ( 12-0-tetradecanoylphorbol-13-
acetate) on mouse ears (Masuda eta/., 1992). 
f) Antioxidant effect Shantanova (1998) had reported that the administration of dry 
extract of Orthosiphon stamineus, Benth., Desmodium canadensis D.S., Poligonum 
aviculare L., Arctostaphylos uva-ursi L., to post-ischemic acute renal insufficiency white 
rats decreased the concentration of lipid peroxidase products in rat kidneys and 
markedly inhibit haemolysis. The inhibition of haemolysis was due to inactivation of 
free radical particles by binding it with phenolic compounds in the preparations. The 
leaves extract of herb are believed to have highest antioxidant property as compared 
to other part of herb studied (Chung eta/., 1998). 
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g) Nitric oxide inhibition effect: Three highly oxygenated isopimarane-type 
diterpenes, (siphonol A-C) and a norisopimarane-type diterpene named siphonol E 
were isolated from the methanolic extract of 0. stamineus sh0wed more potent 
inhibitory effects on nitric oxide (NO) production in lipopolysaccharide (LPS) activated 
macrophage-like J774.1 cells than NG-monomethyh-arginine (L-NMMA) 
(Awale eta/., 2002). 
1.2.4 Herb-drug interaction and adverse effects of methanol extract of Misai 
Kucing 
Induction of hepatic enzyme activities in animals following the treatment with 
many natural compounds or traditional medicines which include Gingko bi/oba 
(Fessenden et a/., 2001), grapefruit juice (Lilja eta/., 2000; Kane & Lipsky, 2000), 
St. John's Wort (Hypericum perforatum) (Durr et a/., 2000) and Kava 
(Piper methysticum) (Almeida & Grimsley, 1996) had previously been reported. 
However, there is no previous scientific study reported on the effect of standardised 
methanol extract of Misai Kucing on herb-drug interaction and toxicity in laboratory 
animals and in man. Therefore, we describe for the first time the effect of standardised 
methanol extract of Misai Kucing on phase I and phase II hepatic drug metabolising 
enzymes activity in rat liver and toxicity studies in rat following the Misai Kucing 
methanolic extract treatment. Therefore, our research provides very important 
information about safety and efficacy of the standardised methanol extract of Misai 
Kucing. 
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Figure 1.1 Misai Kucing (Orthosiphon stamineus, Benth) 
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1.2.5 Evaluation of Misai Kucing ( 0. stamineus) chemical constituents 
There are numerous factors which affect the quality, efficacy and safety of the 
extract obtained. These factors include growing conditions. method of drying and 
grinding, different processing methods and solvents used for extraction and also 
storage conditions (Rotblatt & Ziment, 2002). Good Agriculture Practice (GAP), Good 
Processing Practice (GPP) and Good Manufacturing Practice (GMP) are the few 
followed guidelines in order to maintain the quality and standard of the Misai Kucing 
extract obtained. 
In order to maintain the quality of the extract. leaves used for Misai Kucing 
extraction are collected in the late afternoon, from 30-45 days old white flowered 
plants. The leaves are chopped and dried at approximately 40°C for 3 days. Methanol 
extracts of Misai Kucing are prepared by using a proportion of 1 0 g dried leaves in 
1 00 ml of methanol by warming for 4 hours at 40°C. The solution is filtered through 
filter paper (Whatman No.1). concentrated and spray-dried to obtain the crude 
methanol extract of Misai Kucing (Akowuah et a/.. 2004 ). Recent researchers from 
Universiti Sains Malaysia had reported that rosmarinic acid is the main component in 
the standardised methanol extract of Misai Kucing with concentration ranging from 
5.1 % to 29.9% of the total dry leaf weight. Concentrations of 3'-hydroxy-5,6,7,4'-
tetramethoxyflavone (TMF), eupatorin (EUP) and sinensetin (SEN) ranged from 0.05% 
to 0.69%, 0.34% to 3.37% and 0.22% to 1.76% respectively (Akowuah eta/., 2004). 
Sixteen known compounds from methanol extract of Misai Kucing have been 
isolated and identified by Tezuka eta/ (2000). The identified compounds were five new 
isopimarane-type diterpenes (orthosiphols F-J] and two diterpenes [staminols A and B] 
with a novel carbon framework and three new highly-oxygenated stamina-type 
diterpenes [staminolactones A and B and norstaminol A]. Other compounds such as 
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7,3' ,4'-tri-0-methylluteolin, 5-hydroxy-6, 7 ,3' ,4'-tetramethoxyflavone, eupatorin, 
sinensetin, salvigenin, ladanein, tetramethylscutellarein, 6-hydroxy-5, 7 ,4'-
trimethoxyflavone, vomifoliol, aurantiamide acetate, rosmarinic acid, caffeic acid, 
oleanolic acid, ursolic acid, betulinic acid and ~-sitosterol are also identified in the 
same extract (refer to table 1.1 ). Six phenolic compounds from leaves extract of Misai 
Kucing were isolated and identified by Sumaryono et at (1991 ). These identified 
phenolic compounds were caffeoyl tartrate, rosmarinic acid, aurantiamide acetate, 
vomifoliol, caffeic acid and 2, 3-dicaffeoyl tartrate (refer table 1.2). Sinensitine, 
eupatorin, rosmarinic-, cichoric- and caffeic-acids were the main polyphenols identified 
in two tinctures (A: 50 % v/v ethanol and B: 70% v/v ethanol) of Orthosiphon stamineus 
(Oiah eta/., 2003). 
1.3 Hepatic drug metabolism reactions 
1.3.1 Introduction to drug metabolism 
The liver is one of the hardest working organs in the body and works closely 
with other organs system in the body. It is the most abundant organ in the body for 
xenobiotic and drug metabolism and detoxification process (de Ia Iglesia eta/., 1999). 
In general, the term "metabolism" refers to the sum of biochemical reactions in the 
body, including anabolism (building of complex) and catabolism (breakdown of a 
complex). However, drug metabolism or biotransformation is used to describe the 
conversion of drugs or other toxins into metabolites. These reactions are generally 
called biochemical breakdown of the drug. Biotransformation whether completed by the 
P450 system or other enzyme system is rarely a simple process. These reactions 
involve several different processes concurrently and a single metabolic transformation 
does not usually occur. 
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Table 1.1 List of chemical constituents of Orthosiphon stamineus aerial part 
extract (Tezuka eta/., 2000) 
Diterpenes Triterpenes Flavones 
orthosiphols F [1] Oleanolic acid [12] 7,3 ,4-tri- 0-methylluteolin 
[16] 
orthosiphols G [2] ursolic acid [13] eupatorin [17], 
orthosiphols H [3] betulinic acid [14] sinensetin [18], 
orthosiphols I [4] f3-sitosterol [15], 
3'-hydroxy-5,6, 7 ,4·-
tetramethoxyflavone [19] 
orthosiphols J [5] salvigenin [20], 
staminols A [6] ladanein [21], 
staminols 8 [7], Tetramethylscutallarein 
[22], 
staminolactones A [8] 6-hydroxy-5, 7,4-
trimethoxyflavone [23], 
staminolactones 8 [9] kaempferoi-3-0-f3-
glucoside [24], 
norstaminol A [1 0] quercetin-3-0-f3-glucoside 
[25], 
orthosipholl S [11] 
The number in bracket are chemical compounds found in 0. stamineus and their 
individual chemical structures can be found in pages 15-17. 
13 
Table 1.2 List of chemical constituents of Orthosiphon stamineus leaves extract 
(Sumaryono eta/., 1991} 
Phenolic acids 
caffeoyl tartrate [26] 
rosmarinic acid [27] 
aurantiamide acetate [28], 
vomifoliol [29], 
caffeic acid [30], 
2, 3-dicaffeoyl tartrate [31] 
The number in bracket are chemical compounds found in 0. stamineus and their 
individual chemical structures can be found in pages 17. 
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As shown in table 1.3, biotransformation reactions have been generally termed 
as phase I (functionalisation reaction), phase II (conjugation) and phase Ill (export of 
the conjugate from cells) (Timbrel!, 2001 ). In phase I reactions, xenobiutics are 
generally converted to more polar, hydroxylated derivatives and these derivatives are 
conjugated with molecules such as glucuronic acid, sulphate or glutathione in phase II 
reaction later and eventually excreted in the urine or bile (Murray, 1998). Xenobiotics 
that already possess a functional group can bypass phase I metabolism and directly 
participate in the conjugation reaction (loannides, 2002). In mammals, a majority of the 
enzyme systems that contribute to phase I and phase II metabolisms are encountered 
in every tissue but particularly in the endoplasmic recticulum and cytosolic fraction of 
the liver (loannides, 2002). 
1.3.1.1 Phase I hepatic drug metabolism reaction 
Main reactions of Phase I (functionalisation) liver metabolising process are 
oxidation, reduction and hydrolysis. The major organ that carries out phase I reaction is 
the liver and the major site within the liver is the endoplasmic reticulum of the liver cell 
(Vainio & Hietanen, 1980). Some phase I hepatic enzymes are found in several 
subcellular compartments. Hepatic enzymes involved in the phase I reactions are 
distributed in many different compartment of the liver and have overlapping substrate 
specificities (refer table 1.4). 
a) Reduction 
Reductase enzymes are found in gut flora and some mammalian tissues. 
Nicotinamide adenine dinucleotide phosphate (NADPH) and Flavin adenine 
dinucleotide (FAD) are required in this reaction as electron donor but the function of 
NADPH is inhibited by oxygen. The major reactions of reduction are azo and nitro 
reduction. Examples of reduction reactions are: 
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i) The conversion of prontosil to sulphanilamide (antibacterial drug) is a well-known 
example of azo reduction reaction which is catalysed by the cytochrome P450 and 
carried out by the reductase enzyme in the gut bacteria (Hodgson & Goldstein, 2001 ). 
ii) Tertiary amide oxides are reduced by cytochrome P450. 
iii) Hydroxylamines is reduced by cytochrome P450 and also reduced by a 
flavoprotein which is part of a system which requires NADH and includes NADH 
cytochrome bs reductase and cytochrome b5 (Timbrel!, 2000). 
b) Oxidation 
The cytochrome P-450s system is involved in many oxidation reaction including 
xenobiotic activation and detoxification (Ortiz de Montellano, 1999). Monooxygenations 
of xenobiotics are the major types of Phase I reaction (Nebbia, 2003). They are also 
known as mixed-function oxidations. In general, the sequences of oxidation reactions 
involve at least four distinct steps: (i) addition of substrate to the enzyme, (ii) donation 
of an electron, (iii) addition of oxygen and rearrangement and (iv) donation of a second 
electron and loss of water. Briefly, mixed-function oxidations involve reactions of one 
atom of the oxygen molecule is being accepted by the substrate while the other oxygen 
atom is reduced to water (Guengerich, 2002). 
Oxidation reactions could be catalysed by enzymes known as microsomal or 
non microsomal oxidation enzymes. Non-microsomal oxidations are subdivided into 
amine oxidation, alcohol and aldehyde oxidation, dehalogenation, purine oxidation and 
aromatization. On the other hand, microsomal oxidation reactions include N-, S- and 
0-dealkylation, N-hydroxylation, aliphatic hydroxylation, alicyclic hydroxylation, 
N-oxidation and deamination (Timbrel!, 2000). 
c) Hydrolysis 
Major hydrolysis reactions are ester and amide hydrolysis 
(Hodgson & Goldstein, 2001). Enzymes involved in catalysing hydrolysis reactions are 
carboxylesterases and amidases. Carboxylesterases and amidases are usually found 
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in the cytosol and some have been described in the microsomes. Hydrazines and 
carbamates may undergo hydrolysis reaction. The insecticide, carbaryl is hydrolysed 
to 1-naphthol by hydrolysis reaction (Timbrel~. 2000). 
d) Hydration 
Epoxide may undergo addition of water upon hydration reaction. Hydration 
reaction involves addition of water to the epoxide catalysed by epoxide hydrolase, 
probably by nucleophilic attack by OH- on one of the carbon atom of the oxirane ring to 
yield a dihydrodiol (Gibson & Skett, 1994). 
1.3.1.2 Phase II hepatic drug metabolism reaction 
The phase II hepatic metabolising reactions include glucuronidation, glutathione 
conjugation, sulphate conjugation, amino acid conjugation, hydration, methylation and 
acetylation. Enzymes which are responsible for the phase II conjugation are located 
within various subcellular fraction of the liver (Table 1.5). Phase II reaction generally 
conjugates with a specific substitute group such as glucuronic acid, sulphate, amino 
acid or glutathione to the substrate and thereby increase its size and molecular weight. 
However, methylation and acetylation are exceptions and they may decrease both the 
substrate polarity and its solubility in water (Murray, 1998). 
Enzymes that catalyse phase II reactions similar to the cytochrome P450 
system, are subjected to induction. Induction of phase II hepatic metabolising enzymes 
could be beneficial to the liver itself because it enhances the clearance of toxic or non 
toxic intermediate metabolites. Below are a few of common phase II reactions: 
i) Glucuronidation is the major metabolism pathway. In these reactions, 
UDP-glucuronosyltransferase (UGT) or glucuronidase enzyme adds glucuronic acid to 
a substrate. The conjugation product has a relatively high molecular weight and is 
prone to excretion through bile and urine (Orzechowski eta/., 1994). The most readily 
conjugated functional groups are phenols, alcohols and carboxylic acids. 
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ii) Glutathione conjugation is catalysed by glutathione-S-transferase (GST) which is 
localized primarily in the cytosol and to much lesser extent in the endoplasmic 
reticulum. The major purpose of the glutathione conjugation appears to be the control 
of reactive electrophiles which are present naturally or form metabolism and have a 
deleterious effect on the body (Wilce & Parker, 1994). 
iii) During sulphate conjugation, inorganic sulphate, in the form of 
3'-phosphoadenosine-5'-phosphosulphate (PAPS) is added to the molecule and this 
reaction is catalysed by sulphotransferase (Pacifici & Giuliani, 1997). The phenols and 
amino groups are among the groups to be sulphated to yield readily excretable 
sulphamates. 
iv) Acetylation is another important phase II reaction. An amide bond is formed 
between the amino group of the chemical and acetate. Aromatic and heterocyclic 
amines, hydrazines and sulphonamides may be undergoing acetylation reaction 
(Murray, 1998). 
v) Glycine being the most common amino acid group is found to conjugate with 
xenobiotics. Other amino acids such as glutamine, taurine and ornithine are also 
important in the amino acid conjugation. Amino acid conjugation is formed by peptide 
bond between carboxyl groups of the xenobiotics with the a-amino group of the amino 
acid (Caldwell, 1982). 
vi) Methylation reaction plays an important role in the metabolism of endogenous 
substrates such as noradrenaline, neurotransmitters (Hirata, 1982) and polyphenolics 
such as the tea flavonoid, epicatechin. Methyltransferase are primarily cytosolic 
enzymes but are also found in the endoplasmic reticulum. 
1.3.1.3 Isolation and subcellular fraction of the liver 
Hepatic cells contain a multitude of metabolising enzymes that are usually 
localised in the specific organelles within the cells. Some of these enzymes may also 
be expressed in other specific organs. This study used freshly isolated perfused 
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hepatocytes and subcellular fraction of the liver as indicator of hepatic phase I and 
phase II drug metabolism respectively. 
Isolated perfused hepatocytes are prepared by using collagenase perfusion 
technique and this technique is widely used by pharmacologists to study drug 
metabolism (Chazouilleres et a/., 1989). Perfusions are normally performed in the 
anterograde direction (from portal vein to cava vein) (Miller, 1973). Isolated perfused 
hepatocytes preserve cells integrity and completely contain cell architecture such as 
the membrane cell, surface receptor, nucleus and hepatic metabolic systems 
(Axelsson eta/., 2003). Viable isolated hepatocytes are seen to undergo active DNA 
synthesis, mitosis, cell proliferation and are more physiological as compared to 
subcellular fraction preparation. In addition, all the cofactors and biochemical 
substances needed for reactions are contained within the hepatocytes (Sinz, 1999). 
Subcellular fractions of the liver consist of two different fractions known as liver 
microsomes and the S-9 cytosolic liver fraction (Ekins et a/., 1999) (Figure 1.2). For 
example, UDP-glucuronosyltransferases (UGT) enzymes are predominantly located 
within the endoplasmic reticulum. Consequently, liver microsomes isolated from the 
liver are most suitable to be used in studying glucuronidation reaction of the drug. The 
advantages of using subcellular fractions in drug metabolism studies are the ease to 
prepare, flexibility of incubation conditions such as cofactors, buffer, pH and 
temperature and their stability in long-term storage under specific temperature and 
condition. The disadvantages of hepatic subcellular preparation are the disruption of 
the hepatic cellular heterogeneity by homogenisation and the limitations of sequential 
metabolism that requires multiple cofactors to be completed. However, this limitation 
becomes an advantage when the mechanism of the reactions can be controlled by 
adding suitable cofactor at a specific time and eases the detection at each single step 
of the drug metabolism reaction (Ekins eta/., 1999). 
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1.3.2 Herb-drug interaction 
There is an increasing use of alternative medicine by the public with a variety of 
plant-derived drugs or plant-based supplements which contain active compounds over 
the counter. Moreover, there are possibilities where patients seek herbalist treatment 
while taking prescribed medication. It is possible that one substance may alter the 
bioavailability of another substance by inducing the phase I and phase II hepatic 
enzymes system and subsequently affect drug therapeutic effect or even generate 
toxicity when two or more substances are given concurrently. There are many 
documented reports about herb-drug interactions in human (Roblatt & Ziment, 2002; 
Table 1.6). Herb-drug interaction can be defined as any alteration either in the 
pharmacokinetic or pharmacodynamic effect of the drug caused by concurrent 
treatment with herb and drug. Herb-drug interaction can be generally divided into 
pharmacokinetic and pharmacodynamic interactions (Sugiyama eta/., 2004). 
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Table 1.3 Major biotransformation reaction (Timbrel!, 2000). 
PHASE I PHASE II 
Oxidation Glucuronidation 
Reduction Glutathione conjugation 
Hydrolysis Sulphation 
Hydration Acetylation 
Amino acid conjugation 
Methylation 
PHASE Ill 
Further metabolism of 
glutathione conjugate 
